Heart Failure

Emory University, Medical Department publishes research in heart failure

Published in Medical Imaging Business Week, March 12th, 2009

According to a study from the United States, "Cardiac resynchronization therapy (CRT) has shown benefits in patients with end-stage heart failure (HF) (NYHA class III or IV), depressed left ventricular (LV) ejection fraction, and prolonged QRS duration (> 120 ms). However, at least 30% of the patients who meet the above criteria show no response to CRT."

"It has shown with echocardiography that the presence of W mechanical dyssynchrony is an important predictor for response to CRT. However, echocardiography requires expertise to produce reproducible and reliable results. The recent report from the Predictors of Response to Cardiac Resynchronization Therapy trial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Business Week

Source: Medical Imaging Business Week (2009-03-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry